Carmichael Hill & Associates’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.46K Hold
195
﹤0.01% 669
2024
Q2
$3.82K Hold
195
﹤0.01% 660
2024
Q1
$3.66K Buy
+195
New +$3.54K ﹤0.01% 653
2023
Q4
Sell
-192
Closed -$3.53K 797
2023
Q3
$3.53K Hold
192
﹤0.01% 666
2023
Q2
$3.86K Hold
192
﹤0.01% 657
2023
Q1
$4.22K Hold
192
﹤0.01% 650
2022
Q4
$4.81K Hold
192
﹤0.01% 627
2022
Q3
$4K Hold
192
﹤0.01% 688
2022
Q2
$5K Hold
192
﹤0.01% 649
2022
Q1
$7K Hold
192
﹤0.01% 646
2021
Q4
$7K Hold
192
﹤0.01% 659
2021
Q3
$6K Buy
192
+85
+79% +$3.01K ﹤0.01% 662
2021
Q2
$4K Hold
107
﹤0.01% 689
2021
Q1
$3K Hold
107
﹤0.01% 692
2020
Q4
$3K Hold
107
﹤0.01% 664
2020
Q3
$3K Hold
107
﹤0.01% 626
2020
Q2
$3K Hold
107
﹤0.01% 595
2020
Q1
$3K Hold
107
﹤0.01% 572
2019
Q4
$4K Buy
+107
New +$3.74K ﹤0.01% 577

Other funds holding DOC

Carmichael Hill & Associates's DOC Position: Q3 2024 in Review

Carmichael Hill & Associates held its Healthpeak Properties (DOC) position steady in Q3 2024 at 195 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Carmichael Hill & Associates first reported a position in DOC in Q4 2019 and has held it in 19 quarters since. The position peaked at $7K in Q1 2022. 733 funds tracked by Wall St. Rank hold DOC as of Q3 2024.

  • Carmichael Hill & Associates held 195 shares of Healthpeak Properties worth $4.46K as of Q3 2024.
  • Carmichael Hill & Associates left its Healthpeak Properties share count unchanged in Q3 2024.
  • Healthpeak Properties made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #669 holding.
  • Carmichael Hill & Associates first reported a position in Healthpeak Properties in Q4 2019 and has held it in 19 quarters since.
  • Carmichael Hill & Associates's Healthpeak Properties position peaked at $7K in Q1 2022.
  • 733 funds tracked by Wall St. Rank held Healthpeak Properties as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.